메뉴 건너뛰기




Volumn 62, Issue 10, 2008, Pages 730-731

Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis

Author keywords

Berberine; Hepatitis B; Hepatitis C; Hyperlipidemia; Liver cirrhosis; Liver function tests

Indexed keywords

BERBERINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 56049101177     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.01.007     Document Type: Letter
Times cited : (48)

References (6)
  • 1
    • 0036096053 scopus 로고    scopus 로고
    • Can "statins" be used in patients with hepatitis B?
    • Safeer R.S. Can "statins" be used in patients with hepatitis B?. Postgrad Med 111 (2002) 119-120
    • (2002) Postgrad Med , vol.111 , pp. 119-120
    • Safeer, R.S.1
  • 2
    • 15944410609 scopus 로고    scopus 로고
    • Intensive lipid lowering with atorvastatin in patients with stable coronary disease
    • LaRosa J.C., Grundy S.M., Waters D.D., Shear C., Barter P., Fruchart J.C., et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352 (2005) 1425-1435
    • (2005) N Engl J Med , vol.352 , pp. 1425-1435
    • LaRosa, J.C.1    Grundy, S.M.2    Waters, D.D.3    Shear, C.4    Barter, P.5    Fruchart, J.C.6
  • 3
    • 33748042671 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
    • Shitara Y., and Sugiyama Y. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther 112 (2006) 71-105
    • (2006) Pharmacol Ther , vol.112 , pp. 71-105
    • Shitara, Y.1    Sugiyama, Y.2
  • 4
    • 33646558252 scopus 로고    scopus 로고
    • Clinical perspectives of statin-induced rhabdomyolysis
    • Antons K.A., Williams C.D., Baker S.K., and Phillips P.S. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 119 (2006) 400-409
    • (2006) Am J Med , vol.119 , pp. 400-409
    • Antons, K.A.1    Williams, C.D.2    Baker, S.K.3    Phillips, P.S.4
  • 5
    • 19944374769 scopus 로고    scopus 로고
    • Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
    • Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10 (2004) 1344-1351
    • (2004) Nat Med , vol.10 , pp. 1344-1351
    • Kong, W.1    Wei, J.2    Abidi, P.3    Lin, M.4    Inaba, S.5    Li, C.6
  • 6
    • 11144294840 scopus 로고
    • Experience of berberine in the treatment of diarrhea
    • Luo L.J. Experience of berberine in the treatment of diarrhea. Chin J Med 41 (1955) 452-455
    • (1955) Chin J Med , vol.41 , pp. 452-455
    • Luo, L.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.